Among the identified genetic variations, MYCN amplification (32.1%), 11q loss (47.5%) and 17q gain (80.4%) were the most frequently observed ones (around 90% in total) in individuals with a high risk of developing NB [23]. The gene discussed is MYCN; the disease is neuroblastoma.